Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-1|1|291|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-2|1|382|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-3|1|401|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-4|1|447|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-5|1|447|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-6|1|487|Other deterministic changes|Lower respiratory system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-7|1|494|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-8|1|499|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-9|1|521|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-10|1|539|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-11|1|591|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-12|1|603|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-13|1|619|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-14|1|627|Other deterministic changes|Lower respiratory system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-15|1|627|Other deterministic changes|Lower respiratory system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-1|1|291|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-2|1|382|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-3|1|401|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-4|1|447|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-5|1|447|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-6|1|487|Other deterministic changes|Lower respiratory system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-7|1|494|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-8|1|499|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-9|1|521|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-10|1|539|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-11|1|591|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-12|1|603|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-13|1|619|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-14|1|627|Other deterministic changes|Lower respiratory system|n/a|
2-14-1|NETR-CO-Gy 1.5,12/79|2|92|coffeine|15|milligrams per day|Ingestion in food or water|oral|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-1-15|1|627|Other deterministic changes|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-1|2|284|Other deterministic changes|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-2|2|295|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-3|2|322|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-4|2|390|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-5|2|396|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-6|2|403|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-7|2|421|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-8|2|435|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-9|2|440|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-10|2|468|Neoplasia malignant|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-11|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-12|2|505|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-13|2|534|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-14|2|541|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-15|2|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-16|2|576|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-17|2|600|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-18|2|653|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-19|2|653|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-20|2|672|Other deterministic changes|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-1|2|284|Other deterministic changes|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-2|2|295|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-3|2|322|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-4|2|390|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-5|2|396|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-6|2|403|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-7|2|421|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-8|2|435|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-9|2|440|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-10|2|468|Neoplasia malignant|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-11|2|476|Other deterministic changes|Lower respiratory system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-12|2|505|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-13|2|534|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-14|2|541|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-15|2|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-16|2|576|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-17|2|600|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-18|2|653|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-19|2|653|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-2|NETR-CO-Gy 2.3,4/79|2|222|coffeine|15|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-2-20|2|672|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-1|3|266|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-2|3|386|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-3|3|392|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-4|3|404|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-5|3|442|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-6|3|456|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-7|3|517|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-8|3|558|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-9|3|565|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-10|3|565|Neoplasia malignant|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-11|3|582|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-12|3|600|Neoplasia malignant|Lower digestive tract,MA: 0001900 - gastrointestinal system mesentery|,MPATH: 551 - sarcoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-13|3|621|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-14|3|639|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-15|3|656|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-16|3|667|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-17|3|688|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-18|3|742|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-19|3|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-3|NETR-WI-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-20|3|742|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-1|3|266|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-2|3|386|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-3|3|392|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-4|3|404|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-5|3|442|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-6|3|456|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-7|3|517|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-8|3|558|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-9|3|565|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-10|3|565|Neoplasia malignant|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-11|3|582|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-12|3|600|Neoplasia malignant|Lower digestive tract,MA: 0001900 - gastrointestinal system mesentery|,MPATH: 551 - sarcoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-13|3|621|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-14|3|639|Other deterministic changes|Lower respiratory system|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-15|3|656|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-16|3|667|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-17|3|688|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-18|3|742|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-19|3|742|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-3|NETR-WI-Gy 1.5,4/79|2|222|wine||unit code not relevant|Ingestion in food or water|red wine oral ad lib|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-3-20|3|742|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-1|4|197|Other deterministic changes|Whole body|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-2|4|366|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-3|4|492|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-4|4|527|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-5|4|543|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-6|4|543|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-7|4|551|Other deterministic changes|Lower respiratory system|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-8|4|551|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-9|4|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-10|4|569|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-11|4|578|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-12|4|589|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-13|4|621|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-14|4|666|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-15|4|675|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-16|4|684|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-17|4|691|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-18|4|696|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-19|4|703|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-20|4|733|Neoplasia malignant|Lower respiratory system|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-1|4|197|Other deterministic changes|Whole body|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-2|4|366|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-3|4|492|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-4|4|527|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-5|4|543|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-6|4|543|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-7|4|551|Other deterministic changes|Lower respiratory system|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-8|4|551|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-9|4|554|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-10|4|569|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-11|4|578|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-12|4|589|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-13|4|621|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-14|4|666|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-15|4|675|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-16|4|684|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-17|4|691|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-18|4|696|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-19|4|703|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-4|NETR-SU-Gy 1.5,4/79|2|222|sugar||unit code not relevant|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-4-20|4|733|Neoplasia malignant|Lower respiratory system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-1|5|309|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-2|5|322|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-3|5|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-4|5|345|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-5|5|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-6|5|397|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-7|5|399|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-8|5|422|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-9|5|474|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-10|5|479|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-11|5|483|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 408 - soft tissue fibrosarcoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-12|5|525|Neoplasia malignant|Lower digestive tract,MA: 0001900 - gastrointestinal system mesentery|,MPATH: 551 - sarcoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-13|5|541|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-14|5|549|Other deterministic changes|Lower respiratory system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-15|5|551|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-16|5|610|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-17|5|664|Other deterministic changes|Lower respiratory system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-18|5|692|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-19|5|728|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-20|5|732|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-1|5|309|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-2|5|322|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-3|5|336|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-4|5|345|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-5|5|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-6|5|397|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-7|5|399|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-8|5|422|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-9|5|474|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-10|5|479|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-11|5|483|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|metastatic,MPATH: 408 - soft tissue fibrosarcoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-12|5|525|Neoplasia malignant|Lower digestive tract,MA: 0001900 - gastrointestinal system mesentery|,MPATH: 551 - sarcoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-13|5|541|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-14|5|549|Other deterministic changes|Lower respiratory system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-15|5|551|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-16|5|610|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-17|5|664|Other deterministic changes|Lower respiratory system|n/a|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-18|5|692|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-19|5|728|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-5|NETR-AS-Gy 1.5,4/79|2|222|aspirine|10|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-5-20|5|732|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-1|6|244|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-2|6|342|Other deterministic changes|Whole body|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-3|6|367|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-4|6|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-5|6|423|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-6|6|454|Hyperplastic changes|Lower respiratory system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-7|6|471|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-8|6|471|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-9|6|498|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-10|6|507|Other deterministic changes|Lower respiratory system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-11|6|526|Other deterministic changes|Lower respiratory system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-12|6|542|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-13|6|561|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-14|6|572|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-15|6|610|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-16|6|638|Neoplasia malignant|Reproductive system,MA: 0000411 - testis|,MPATH: 218 - neoplasm|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-17|6|642|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-18|6|642|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-19|6|653|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-20|6|666|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-1|6|244|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-2|6|342|Other deterministic changes|Whole body|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-3|6|367|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-4|6|400|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-5|6|423|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-6|6|454|Hyperplastic changes|Lower respiratory system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-7|6|471|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-8|6|471|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-9|6|498|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-10|6|507|Other deterministic changes|Lower respiratory system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-11|6|526|Other deterministic changes|Lower respiratory system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-12|6|542|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-13|6|561|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-14|6|572|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-15|6|610|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-16|6|638|Neoplasia malignant|Reproductive system,MA: 0000411 - testis|,MPATH: 218 - neoplasm|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-17|6|642|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-18|6|642|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-19|6|653|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-6|NETR-VA-Gy 2.3,4/79|2|222|valium|0.1|milligrams per day|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-6-20|6|666|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|1|92|neutrons fission|2.8|grays|External exposure|Triton|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-1|7|405|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-7|NETR-aBN-Gy 2.8,5/78|1|92|neutrons fission|2.8|grays|External exposure|Triton|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-2|7|486|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|1|92|neutrons fission|2.8|grays|External exposure|Triton|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-3|7|536|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|1|92|neutrons fission|2.8|grays|External exposure|Triton|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-4|7|536|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|1|92|neutrons fission|2.8|grays|External exposure|Triton|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-5|7|597|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|1|92|neutrons fission|2.8|grays|External exposure|Triton|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-6|7|597|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|2|315|ANF alpha-naphtoflavone||unit code not relevant|Injection, intramuscular|IM inject|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-1|7|405|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-7|NETR-aBN-Gy 2.8,5/78|2|315|ANF alpha-naphtoflavone||unit code not relevant|Injection, intramuscular|IM inject|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-2|7|486|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|2|315|ANF alpha-naphtoflavone||unit code not relevant|Injection, intramuscular|IM inject|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-3|7|536|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|2|315|ANF alpha-naphtoflavone||unit code not relevant|Injection, intramuscular|IM inject|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-4|7|536|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|2|315|ANF alpha-naphtoflavone||unit code not relevant|Injection, intramuscular|IM inject|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-5|7|597|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-7|NETR-aBN-Gy 2.8,5/78|2|315|ANF alpha-naphtoflavone||unit code not relevant|Injection, intramuscular|IM inject|6 (6 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-7-6|7|597|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-1|8|446|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-2|8|455|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-3|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-4|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-5|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-6|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-7|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-8|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-9|8|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-8|NETR-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-8-10|8|541|Neoplasia benign|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-1|9|402|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-2|9|441|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-3|9|475|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-4|9|476|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-5|9|483|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-6|9|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-7|9|512|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-8|9|515|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-9|9|524|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|1|92|neutrons fission|0.15|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-10|9|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-1|9|402|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-2|9|441|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-3|9|475|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-4|9|476|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-5|9|483|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-6|9|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-7|9|512|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-8|9|515|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-9|9|524|Other deterministic changes|Lower respiratory system|n/a|
2-14-9|NETR-BN-Gy 0.15,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-9-10|9|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-1|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-2|10|541|Hyperplastic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-3|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-4|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-5|10|541|Hyperplastic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-6|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-7|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-8|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-9|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-10|NETR-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-10-10|10|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-1|11|441|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-2|11|444|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-3|11|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-4|11|509|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-5|11|511|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-6|11|521|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-7|11|541|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 549 - carcinoma|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-8|11|541|Hyperplastic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-9|11|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|1|92|neutrons fission|0.23|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-10|11|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-1|11|441|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-2|11|444|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-3|11|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-4|11|509|Neoplasia malignant|Reproductive system,MA: 0000404 - prostate gland|,MPATH: 268 - adenocarcinoma|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-5|11|511|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-6|11|521|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-7|11|541|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 549 - carcinoma|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-8|11|541|Hyperplastic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-9|11|541|Other deterministic changes|Lower respiratory system|n/a|
2-14-11|NETR-BN-Gy 0.23,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-11-10|11|541|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-1|12|323|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-2|12|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-3|12|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-4|12|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-5|12|490|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-6|12|490|Hyperplastic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-7|12|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-8|12|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-9|12|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-12|NETR-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-12-10|12|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-1|13|398|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-2|13|442|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-3|13|461|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-4|13|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-5|13|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-6|13|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-7|13|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-8|13|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-9|13|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-13|NETR-BN-Gy 0.3,4/81|1|92|neutrons fission|0.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-10|13|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-1|13|398|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-2|13|442|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-3|13|461|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-4|13|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-5|13|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-6|13|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-7|13|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-8|13|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-9|13|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-13|NETR-BN-Gy 0.3,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-13-10|13|491|Other deterministic changes|Lower respiratory system|n/a|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-1|14|323|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-2|14|442|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 409 - fibrous histiocytoma|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-3|14|488|Other deterministic changes|Lower respiratory system|n/a|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-4|14|488|Other deterministic changes|Lower respiratory system|n/a|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-5|14|488|Other deterministic changes|Lower respiratory system|n/a|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-6|14|490|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-7|14|490|Other deterministic changes|Lower respiratory system|n/a|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-8|14|490|Neoplasia malignant|Lower respiratory system|n/a|
2-14-14|NETR-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-14-9|14|490|Neoplasia malignant|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-1|15|337|Other deterministic changes|Whole body|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-2|15|337|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-3|15|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-4|15|426|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-5|15|478|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-6|15|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-7|15|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-8|15|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-9|15|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|1|92|neutrons fission|0.45|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-10|15|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-1|15|337|Other deterministic changes|Whole body|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-2|15|337|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-3|15|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-4|15|426|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-5|15|478|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-6|15|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-7|15|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-8|15|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-9|15|484|Other deterministic changes|Lower respiratory system|n/a|
2-14-15|NETR-BN-Gy 0.45,4/81|2|323|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|16 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-15-10|15|484|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-16|NESI-BN-Gy 0.4,10/79|1|92|neutrons fission|0.4|grays|External exposure|Silene|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-1|16|626|Neoplasia benign|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|1|92|neutrons fission|0.4|grays|External exposure|Silene|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-2|16|663|Other deterministic changes|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|1|92|neutrons fission|0.4|grays|External exposure|Silene|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-3|16|698|Other deterministic changes|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|1|92|neutrons fission|0.4|grays|External exposure|Silene|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-4|16|698|Other deterministic changes|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|2|595|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-1|16|626|Neoplasia benign|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|2|595|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-2|16|663|Other deterministic changes|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|2|595|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-3|16|698|Other deterministic changes|Lower respiratory system|n/a|
2-14-16|NESI-BN-Gy 0.4,10/79|2|595|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-16-4|16|698|Other deterministic changes|Lower respiratory system|n/a|
2-14-17|NETR-BN105d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-1|17|311|Other deterministic changes|Lower respiratory system|n/a|
2-14-17|NETR-BN105d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-2|17|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-17|NETR-BN105d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-3|17|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-17|NETR-BN105d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-4|17|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-17|NETR-BN105d-Gy 0.75,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-1|17|311|Other deterministic changes|Lower respiratory system|n/a|
2-14-17|NETR-BN105d-Gy 0.75,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-2|17|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-17|NETR-BN105d-Gy 0.75,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-3|17|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-17|NETR-BN105d-Gy 0.75,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-17-4|17|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-1|18|317|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-2|18|395|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-3|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-4|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-5|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-6|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-7|18|423|Hyperplastic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-8|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-9|18|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-10|18|423|Hyperplastic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-11|18|423|Hyperplastic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-12|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-13|18|423|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-14|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-15|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|1|92|neutrons fission|0.75|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-16|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-1|18|317|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-2|18|395|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-3|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-4|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-5|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-6|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-7|18|423|Hyperplastic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-8|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-9|18|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-10|18|423|Hyperplastic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-11|18|423|Hyperplastic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-12|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-13|18|423|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-14|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-15|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-18|NETR-BN232d-Gy 0.75,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-18-16|18|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-1|19|206|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-2|19|206|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-3|19|206|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-4|19|279|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-1|19|206|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-2|19|206|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-3|19|206|Other deterministic changes|Lower respiratory system|n/a|
2-14-19|NETR-BN105d-Gy 1.1,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-19-4|19|279|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-1|20|392|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-2|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-3|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-4|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-5|20|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-6|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-7|20|422|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-8|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-9|20|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-10|20|422|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-11|20|422|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-12|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-13|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-14|20|422|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-15|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|1|92|neutrons fission|1.1|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-16|20|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-1|20|392|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-2|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-3|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-4|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-5|20|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-6|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-7|20|422|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-8|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-9|20|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-10|20|422|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-11|20|422|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-12|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-13|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-14|20|422|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-15|20|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-20|NETR-BN232d-Gy 1.1,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 5 4 3 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-20-16|20|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-1|21|240|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-2|21|359|Other deterministic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-3|21|442|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-4|21|456|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-5|21|535|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-6|21|560|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-7|21|560|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-8|21|611|Hyperplastic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-9|21|619|Other deterministic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-10|21|676|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-1|21|240|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-2|21|359|Other deterministic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-3|21|442|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-4|21|456|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-5|21|535|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-6|21|560|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-7|21|560|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 426 - leiomyosarcoma|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-8|21|611|Hyperplastic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-9|21|619|Other deterministic changes|Lower respiratory system|n/a|
2-14-21|NETR-BN4d-Gy 1.5,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-21-10|21|676|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-14-22|NETR-BN105d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-1|22|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-22|NETR-BN105d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-2|22|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-22|NETR-BN105d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-3|22|317|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-22|NETR-BN105d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-4|22|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-22|NETR-BN105d-Gy 1.5,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-1|22|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-22|NETR-BN105d-Gy 1.5,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-2|22|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-22|NETR-BN105d-Gy 1.5,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-3|22|317|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-22|NETR-BN105d-Gy 1.5,6/80|2|197|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|8 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-22-4|22|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-1|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-2|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-3|23|423|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-4|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-5|23|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-6|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-7|23|423|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-8|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-9|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-10|23|423|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-11|23|423|Neoplasia malignant|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-12|23|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-13|23|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-14|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-15|23|423|Neoplasia benign|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|1|92|neutrons fission|1.5|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-16|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-1|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-2|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-3|23|423|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-4|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-5|23|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-6|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-7|23|423|Neoplasia malignant|Bloodvessels among cardiovascular system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-8|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-9|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-10|23|423|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-11|23|423|Neoplasia malignant|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-12|23|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-13|23|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-14|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-15|23|423|Neoplasia benign|Lower respiratory system|n/a|
2-14-23|NETR-BN232d-Gy 1.5,6/80|2|224|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(7 6 5 4 combined) IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-23-16|23|423|Other deterministic changes|Lower respiratory system|n/a|
2-14-24|NETR-BN150d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-1|24|275|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-14-24|NETR-BN150d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-2|24|287|Other deterministic changes|Lower respiratory system|n/a|
2-14-24|NETR-BN150d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-3|24|298|Other deterministic changes|Lower respiratory system|n/a|
2-14-24|NETR-BN150d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-4|24|298|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-24|NETR-BN150d-Gy 2.2,6/80|2|242|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-1|24|275|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-14-24|NETR-BN150d-Gy 2.2,6/80|2|242|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-2|24|287|Other deterministic changes|Lower respiratory system|n/a|
2-14-24|NETR-BN150d-Gy 2.2,6/80|2|242|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-3|24|298|Other deterministic changes|Lower respiratory system|n/a|
2-14-24|NETR-BN150d-Gy 2.2,6/80|2|242|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|4 (4 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-24-4|24|298|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-1|25|273|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-2|25|338|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-3|25|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-4|25|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-5|25|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-6|25|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-7|25|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-8|25|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-9|25|422|Neoplasia malignant|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-10|25|422|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-11|25|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-12|25|422|Neoplasia benign|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-13|25|422|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-14|25|422|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-15|25|422|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|1|92|neutrons fission|2.2|grays|External exposure|Triton|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-16|25|422|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-1|25|273|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-2|25|338|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-3|25|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-4|25|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-5|25|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-6|25|422|Hyperplastic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-7|25|422|Other deterministic changes|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-8|25|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-9|25|422|Neoplasia malignant|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-10|25|422|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|metastatic,MPATH: 268 - adenocarcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-11|25|422|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-12|25|422|Neoplasia benign|Lower respiratory system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-13|25|422|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-14|25|422|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-15|25|422|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-25|NETR-BN212d-Gy 2.2,6/80|2|324|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 IM inject.|16 (16 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-25-16|25|422|Neoplasia malignant|Lymphatic vessels among cardiovascular system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-1|26|1|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-2|26|1|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-3|26|1|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-4|26|11|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-5|26|59|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-6|26|74|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-7|26|78|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-8|26|78|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-9|26|85|Hyperplastic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-10|26|85|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-11|26|87|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-12|26|89|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-13|26|89|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-14|26|218|Hyperplastic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-15|26|218|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-1|26|1|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-2|26|1|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-3|26|1|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-4|26|11|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-5|26|59|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-6|26|74|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-7|26|78|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-8|26|78|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-9|26|85|Hyperplastic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-10|26|85|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-11|26|87|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-12|26|89|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-13|26|89|Other deterministic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-14|26|218|Hyperplastic changes|Lower respiratory system|n/a|
2-14-26|NETR-BN-104d-Gy 2.3,12/79|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject. -104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-26-15|26|218|Other deterministic changes|Lower respiratory system|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-1|27|267|Other deterministic changes|Whole body|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-2|27|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-3|27|456|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-4|27|467|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-5|27|485|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-6|27|485|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-7|27|607|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-8|27|611|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-9|27|642|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-10|27|691|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-1|27|267|Other deterministic changes|Whole body|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-2|27|442|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-3|27|456|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-4|27|467|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-5|27|485|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-6|27|485|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-7|27|607|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-8|27|611|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-9|27|642|Neoplasia malignant|Liver among hepato-pancreatic system diseases|n/a|
2-14-27|NETR-BN4d-Gy 2.3,10/77|2|96|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-27-10|27|691|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-1|28|249|Other deterministic changes|Lower respiratory system|n/a|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-2|28|279|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-3|28|280|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-4|28|284|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-5|28|284|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-6|28|284|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-7|28|284|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-8|28|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-9|28|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-10|28|292|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-11|28|292|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-12|28|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-13|28|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-14|28|312|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-15|28|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-16|28|348|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-17|28|360|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-18|28|375|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-19|28|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-20|28|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-1|28|249|Other deterministic changes|Lower respiratory system|n/a|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-2|28|279|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-3|28|280|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-4|28|284|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-5|28|284|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-6|28|284|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-7|28|284|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-8|28|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-9|28|288|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-10|28|292|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-11|28|292|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-12|28|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-13|28|297|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-14|28|312|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-15|28|317|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-16|28|348|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-17|28|360|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-18|28|375|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-19|28|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-28|NETR-BN117d-Gy 2.3,4/79|2|209|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|12 IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-28-20|28|378|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-1|29|271|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-2|29|282|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-3|29|282|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-4|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-5|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-6|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-7|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-8|29|302|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-9|29|302|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-10|29|317|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-11|29|338|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-12|29|399|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-13|29|421|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-14|29|430|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-15|29|457|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-16|29|464|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-17|29|507|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|1|92|neutrons fission|0|grays|External exposure|Triton|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-18|29|749|Other deterministic changes|Lower respiratory system|n/a|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-1|29|271|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-2|29|282|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-3|29|282|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-4|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-5|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-6|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-7|29|284|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-8|29|302|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-9|29|302|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-10|29|317|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-11|29|338|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-12|29|399|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-13|29|421|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-14|29|430|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-15|29|457|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-16|29|464|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-17|29|507|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-29|NETR-BP.06-Gy 0,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-29-18|29|749|Other deterministic changes|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-1|30|375|Other deterministic changes|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-2|30|392|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-3|30|392|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-4|30|400|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-5|30|437|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-6|30|454|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-7|30|478|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-8|30|478|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-9|30|483|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-10|30|490|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-11|30|493|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-12|30|528|Other deterministic changes|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-13|30|528|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-14|30|528|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-15|30|528|Neoplasia benign|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-16|30|528|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-17|30|584|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-18|30|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-19|30|636|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-20|30|650|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-1|30|375|Other deterministic changes|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-2|30|392|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-3|30|392|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-4|30|400|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-5|30|437|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-6|30|454|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-7|30|478|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-8|30|478|Neoplasia malignant|Reproductive system,MA: 0000396 - male reproductive system|,MPATH: 551 - sarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-9|30|483|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-10|30|490|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-11|30|493|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-12|30|528|Other deterministic changes|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-13|30|528|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-14|30|528|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-15|30|528|Neoplasia benign|Lower respiratory system|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-16|30|528|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-17|30|584|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-18|30|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-19|30|636|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-30|NETR-BP.03-Gy 0,4/79|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-30-20|30|650|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-1|31|271|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-2|31|271|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-3|31|271|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-4|31|272|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-5|31|272|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-6|31|272|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-7|31|272|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-8|31|302|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-9|31|302|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-10|31|302|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-11|31|317|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-12|31|338|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-13|31|392|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-14|31|399|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-15|31|399|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-16|31|421|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-17|31|449|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-18|31|640|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-19|31|712|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|1|92|neutrons fission|1.5|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-20|31|712|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 549 - carcinoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-1|31|271|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-2|31|271|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-3|31|271|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-4|31|272|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-5|31|272|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-6|31|272|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-7|31|272|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-8|31|302|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-9|31|302|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-10|31|302|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-11|31|317|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-12|31|338|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-13|31|392|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-14|31|399|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|,MPATH: 551 - sarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-15|31|399|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-16|31|421|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-17|31|449|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-18|31|640|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-19|31|712|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-31|NETR-BP.06-Gy 1.50,2/81|2|92|benzopyrene|0.06|milligrams|Injection, intramuscular|IM inject.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-31-20|31|712|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 549 - carcinoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-1|32|236|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-2|32|253|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-3|32|253|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-14-32|NETR-BP.3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-4|32|259|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-5|32|259|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|2|92|benzopyrene|0.3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-1|32|236|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|2|92|benzopyrene|0.3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-2|32|253|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|2|92|benzopyrene|0.3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-3|32|253|Neoplasia benign|Bloodvessels among cardiovascular system|n/a|
2-14-32|NETR-BP.3-Gy 1.5,10/77|2|92|benzopyrene|0.3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-4|32|259|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-32|NETR-BP.3-Gy 1.5,10/77|2|92|benzopyrene|0.3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-32-5|32|259|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-1|33|236|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-2|33|251|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-3|33|251|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-4|33|251|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|1|92|neutrons fission|1.5|grays|External exposure|Triton|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-5|33|277|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|2|92|benzopyrene|3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-1|33|236|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|2|92|benzopyrene|3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-2|33|251|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|2|92|benzopyrene|3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-3|33|251|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|2|92|benzopyrene|3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-4|33|251|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-33|NETR-BP3-Gy 1.5,10/77|2|92|benzopyrene|3|milligrams|Injection, intramuscular|IM inject.|5 (5 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-33-5|33|277|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-1|34|247|Other deterministic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-2|34|331|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-3|34|368|Other deterministic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-4|34|425|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-5|34|472|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-6|34|472|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-7|34|477|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-8|34|487|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-9|34|496|Other deterministic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-10|34|498|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-11|34|507|Hyperplastic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-12|34|561|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-13|34|586|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-14|34|607|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-15|34|635|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-1|34|247|Other deterministic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-2|34|331|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-3|34|368|Other deterministic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-4|34|425|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-5|34|472|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-6|34|472|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-7|34|477|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-8|34|487|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-9|34|496|Other deterministic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-10|34|498|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-11|34|507|Hyperplastic changes|Lower respiratory system|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-12|34|561|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-13|34|586|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-14|34|607|Neoplasia malignant|Musculo-skeletal system,MA: 0000015 - muscle organ|,MPATH: 428 - rhabdomyosarcoma|
2-14-34|NETR-BP.04m-Gy 2.3,12/79|2|92|benzopyrene|0.04|milligrams|Injection, intramuscular|IM inject.-104d?|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-34-15|34|635|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-1|35|41|Other deterministic changes|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-2|35|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-3|35|218|Other deterministic changes|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-4|35|325|Neoplasia malignant|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-5|35|367|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 551 - sarcoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-6|35|396|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-7|35|415|Neoplasia benign|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-8|35|424|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-9|35|427|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-10|35|510|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-11|35|526|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-12|35|526|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-13|35|526|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-14|35|543|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-15|35|543|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-16|35|546|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 551 - sarcoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-17|35|615|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-18|35|640|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-19|35|657|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-20|35|657|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-1|35|41|Other deterministic changes|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-2|35|192|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-3|35|218|Other deterministic changes|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-4|35|325|Neoplasia malignant|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-5|35|367|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 551 - sarcoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-6|35|396|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-7|35|415|Neoplasia benign|Lower respiratory system|n/a|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-8|35|424|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-9|35|427|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|metastatic,MPATH: 549 - carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-10|35|510|Neoplasia malignant|Bloodvessels among cardiovascular system|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-11|35|526|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-12|35|526|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-13|35|526|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-14|35|543|Neoplasia malignant|Liver among hepato-pancreatic system diseases|benign|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-15|35|543|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-16|35|546|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|metastatic,MPATH: 551 - sarcoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-17|35|615|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-18|35|640|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-19|35|657|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|,MPATH: 219 - adnexal and skin appendage tumor|
2-14-35|NETR-BP.04o-Gy 2.3,12/79|2|114|benzopyrene|0.04|milligrams|Ingestion in food or water|oral|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-35-20|35|657|Neoplasia malignant|Adrenal gland  among endocrine systems|n/a|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-1|36|237|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-2|36|527|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-3|36|527|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-4|36|544|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-5|36|564|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-6|36|614|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-7|36|631|Neoplasia malignant|Heart among cardiovascular system,MA: 0000072 - heart|,MPATH: 511 - Myeloproliferation (genetic)|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-8|36|682|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-9|36|697|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-36|NETR-AS-Gy 0,10/77|1|92|neutrons fission|0|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-10|36|718|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-1|36|237|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-2|36|527|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-3|36|527|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-4|36|544|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-5|36|564|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-6|36|614|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-7|36|631|Neoplasia malignant|Heart among cardiovascular system,MA: 0000072 - heart|,MPATH: 511 - Myeloproliferation (genetic)|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-8|36|682|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-9|36|697|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-36|NETR-AS-Gy 0,10/77|2|218|asbestos||unit code not relevant|Injection, intratracheal|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-36-10|36|718|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-1|37|388|Other deterministic changes|Whole body|n/a|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-2|37|420|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-3|37|472|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-4|37|555|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-5|37|565|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-6|37|594|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-7|37|660|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-8|37|660|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-9|37|660|Neoplasia malignant|Lower respiratory system|n/a|
2-14-37|NETR-AS-Gy 2.30,10/77|1|92|neutrons fission|2.3|grays|External exposure|Triton|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-10|37|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-1|37|388|Other deterministic changes|Whole body|n/a|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-2|37|420|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-3|37|472|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-4|37|555|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-5|37|565|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-6|37|594|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-7|37|660|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-8|37|660|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-9|37|660|Neoplasia malignant|Lower respiratory system|n/a|
2-14-37|NETR-AS-Gy 2.30,10/77|2|127|asbestos||unit code not relevant|Injection intrapleural|intratracheal|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-37-10|37|700|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-1|38|289|Other deterministic changes|Lower respiratory system|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-2|38|431|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 551 - sarcoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-3|38|458|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-4|38|484|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-5|38|494|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-6|38|513|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland|benign,MPATH: 549 - carcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-7|38|519|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-8|38|519|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-9|38|524|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-10|38|526|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-11|38|528|Neoplasia malignant|Lower respiratory system|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-12|38|528|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-13|38|539|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-14|38|539|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|1|92|neutrons fission|2.3|grays|External exposure|Triton|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-15|38|539|Neoplasia malignant|Lower respiratory system|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-1|38|289|Other deterministic changes|Lower respiratory system|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-2|38|431|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 551 - sarcoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-3|38|458|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-4|38|484|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-5|38|494|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-6|38|513|Neoplasia malignant|Upper digestive tract,MA: 0000346 - salivary gland|benign,MPATH: 549 - carcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-7|38|519|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-8|38|519|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-9|38|524|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-10|38|526|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|metastatic,MPATH: 278 - follicular adenocarcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-11|38|528|Neoplasia malignant|Lower respiratory system|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-12|38|528|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-13|38|539|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-14|38|539|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-14-38|NETR-CR-Gy 2.3,12/79|2|23|crocidolite||unit code not relevant|Injection intrapleural|intrapleural|15 (15 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-38-15|38|539|Neoplasia malignant|Lower respiratory system|n/a|
2-14-39|NESI-OZ0.4ac-Gy,5/90|1|92|ozone|0.4|parts per million|Inhalation|acute|36 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-40|NESI-OZ0.75c-Gy 0,9/89|1|92|ozone|0.75|parts per million|Inhalation|acute|30 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-41|NESI-OZ2ch-Gy 0,3/91|1|92|ozone|2|parts per million|Inhalation|chronic|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-42|NESI-OZ.4-Gy 0.6,5/90|1|92|neutrons fission|0.6|grays|External exposure|n/a|36 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-42|NESI-OZ.4-Gy 0.6,5/90|2|92|ozone|0.4|parts per million|Inhalation|acute|36 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-43|NESI-OZ.75Gy 0.6,6/89|1|92|neutrons fission|0.6|grays|External exposure|n/a|30 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-43|NESI-OZ.75Gy 0.6,6/89|2|92|ozone|0.75|parts per million|Inhalation|acute|30 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-44|NESI-Pb-Gy 0,5/90|1|92|PbO||unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-45|NESI-PbBNF-Gy 0,5/90|1|92|PbO||unit code not relevant|not applicable or not supplied|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-45|NESI-PbBNF-Gy 0,5/90|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-46|NESI-PbBNF-Gy 0.6,5/90|1|92|neutrons fission|0.6|grays|External exposure|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-46|NESI-PbBNF-Gy 0.6,5/90|2|92|PbO||unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-47|NESI-Cd-Gy 0,5/90|1|92|cadmium chloride||unit code not relevant|not applicable or not supplied|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-48|NESI-CdBNF-Gy 0,5/90|1|92|cadmium chloride||unit code not relevant|not applicable or not supplied|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-48|NESI-CdBNF-Gy 0,5/90|2|92|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-49|NESI-Cdinh-Gy 0,11/89|1|92|cadmium chloride|0.7|milligram per cubic m|Inhalation|n/a|30 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-50|NESI-Cd-Gy 0.6,9/89|1|92|neutrons fission|0.6|grays|External exposure|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-50|NESI-Cd-Gy 0.6,9/89|2|92|cadmium chloride||unit code not relevant|not applicable or not supplied|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-51|NESI-As-Gy 0,5/92|1|92|As trioxide|0.5|milligram per cubic m|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-52|NESI-As-Gy 0.6,5/92|1|92|neutrons fission|0.6|grays|External exposure|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-52|NESI-As-Gy 0.6,5/92|2|92|As trioxide|0.5|milligram per cubic m|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-53|RnfLM 500,10/91|1|92|Rn-222 gas|500|working level months|Inhalation|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|No information on individuals available for this study
2-14-54|RnfLM 500,10/91|1|92|Rn-222 gas|500|working level months|Inhalation|n/a|25 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Female|Young Adult|Lifespan study|No information on individuals available for this study
2-14-55|RnWLM 1000,1/91|1|92|Rn-222 gas|1000|working level months|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-56|Rn+OZ0.2ac-WLM 1000,1/91|1|92|Rn-222 gas|1000|working level months|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-56|Rn+OZ0.2ac-WLM 1000,1/91|2|92|ozone|0.2|parts per million|Inhalation|acute|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-57|Rn+OZ2ac-WLM 1000,1/91|1|92|Rn-222 gas|1000|working level months|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-57|Rn+OZ2ac-WLM 1000,1/91|2|92|ozone|2|parts per million|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-58|Rn+OZ2ac-WLM 1000,1/91|1|92|Rn-222 gas|1000|working level months|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-58|Rn+OZ2ac-WLM 1000,1/91|2|92|ozone|2|parts per million|Inhalation|n/a|50 (0 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|No information on individuals available for this study
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-1|59|225|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-2|59|304|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-3|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-4|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-5|59|316|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-6|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-7|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-8|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-9|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|1|92|gamma-rays Co-60|4|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-10|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-1|59|225|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-2|59|304|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-3|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-4|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-5|59|316|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-6|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-7|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-8|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-9|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-59|GA-BN-Gy 4,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|5 IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-59-10|59|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-1|60|253|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-2|60|256|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-3|60|267|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-4|60|296|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-5|60|296|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-6|60|296|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-7|60|296|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-8|60|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-9|60|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|1|92|gamma-rays Co-60|8|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-10|60|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-1|60|253|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-2|60|256|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-3|60|267|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-4|60|296|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-5|60|296|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-6|60|296|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-7|60|296|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-8|60|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-9|60|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-60|GA-BN-Gy 8,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(6 12 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-60-10|60|316|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-1|61|222|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-2|61|256|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-3|61|283|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-4|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-5|61|283|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-6|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-7|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-8|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-9|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|1|92|gamma-rays Co-60|12|grays|External exposure|Co-60|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-10|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-1|61|222|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-2|61|256|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-3|61|283|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-4|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-5|61|283|Neoplasia benign|Upper digestive tract,MA: 0000346 - salivary gland|,MPATH: 218 - neoplasm|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-6|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-7|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-8|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-9|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-61|GA-BN-Gy 12,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(5 10 combined) IM inject.|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-61-10|61|283|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-1|62|208|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-2|62|215|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-3|62|260|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-4|62|260|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-5|62|260|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-6|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-7|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-8|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|1|92|gamma-rays Co-60|16|grays|External exposure|Co-60|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-9|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-1|62|208|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-2|62|215|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-3|62|260|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-4|62|260|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-5|62|260|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-6|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-7|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-8|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-62|GA-BN-Gy 16,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(3 6 combined) IM inject.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-62-9|62|262|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-1|63|64|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-2|63|233|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-3|63|239|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-4|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-5|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-6|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-7|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-8|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-9|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-10|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-11|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-12|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-13|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-14|63|252|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-15|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-16|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-17|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-18|63|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-19|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-20|63|259|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-21|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-22|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-23|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|1|92|gamma-rays Co-60|20|grays|External exposure|Co-60|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-24|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-1|63|64|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-2|63|233|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-3|63|239|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-4|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-5|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-6|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-7|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-8|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-9|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-10|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-11|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-12|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-13|63|240|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-14|63|252|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-15|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-16|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-17|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-18|63|259|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-19|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-20|63|259|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-21|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-22|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-23|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-63|GA-BN-Gy 20,3/81|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-63-24|63|259|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-1|64|73|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-2|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-3|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-4|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-5|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-6|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-7|64|194|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-8|64|200|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-9|64|219|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-10|64|219|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-11|64|219|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-12|64|219|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-13|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-14|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-15|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-16|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-17|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-18|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-19|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-20|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-21|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-22|64|245|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-23|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|1|92|gamma-rays local|15|grays|External exposure|0.5 Gy/min 3mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-24|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-1|64|73|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-2|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-3|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-4|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-5|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-6|64|83|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-7|64|194|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-8|64|200|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-9|64|219|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-10|64|219|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-11|64|219|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-12|64|219|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-13|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-14|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-15|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-16|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-17|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-18|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-19|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-20|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-21|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-22|64|245|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-23|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-64|GA-BN3c-Gy 15,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 5 6 8 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-64-24|64|245|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-1|65|67|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-2|65|67|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-3|65|67|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-4|65|67|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-5|65|67|Neoplasia benign|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-6|65|67|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-7|65|218|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-8|65|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-9|65|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-10|65|230|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-11|65|230|Hyperplastic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|0.5 Gy/min 3 mm collim.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-12|65|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-1|65|67|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-2|65|67|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-3|65|67|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-4|65|67|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-5|65|67|Neoplasia benign|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-6|65|67|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-7|65|218|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-8|65|224|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-9|65|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-10|65|230|Other deterministic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-11|65|230|Hyperplastic changes|Lower respiratory system|n/a|
2-14-65|GA-BN3c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|(4 8 combined) IM inject.|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-65-12|65|230|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-1|66|61|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-2|66|81|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-3|66|81|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-4|66|81|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-5|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-6|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-7|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-8|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-9|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-10|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-11|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-12|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-13|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-14|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-15|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-16|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-17|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-18|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-19|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-20|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-21|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-22|66|197|Other deterministic changes|Lower respiratory system|n/a|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-23|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|1|92|gamma-rays local|20|grays|External exposure|1.4 Gy/min 10 mm collim.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-24|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-1|66|61|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-2|66|81|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-3|66|81|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-4|66|81|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-5|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-6|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-7|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-8|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-9|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-10|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-11|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-12|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-13|66|82|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-14|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-15|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-16|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-17|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-18|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-19|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-20|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-21|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-22|66|197|Other deterministic changes|Lower respiratory system|n/a|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-23|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-14-66|GA-BN9c-Gy 20,1/84|2|148|BNF -naphtoflavone|25|milligrams|Injection, intramuscular|4 5 combined) IM inject.|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-14-66-24|66|197|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
